Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), the Canadian-based leading global medical cannabis company, in conjunction with MedReleaf Australia, recently removed the ...

Artivion, Inc. , a leading cardiac and vascular surgery company focused on aortic disease, announced today that fourth quarter and full year 2024 financial results will be released on Monday, February ...

On Feb. 5, Aurora Cannabis reported its fiscal third-quarter results for the period ended Dec. 31. The cannabis company ...

As a leader in the medical cannabis space, Aurora Cannabis is enjoying premium margins. Read why I rate ACB stock a Strong ...

Shares of Aurora Cannabis Inc. ACB shed 4.68% to $6.31 Friday, on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ Composite Index COMP rising 0.41% to ...

Medical cannabis company Aurora Cannabis (ACB) has surprised markets with a record-breaking third quarter, sending its shares ...

Aurora Cannabis Inc. closed 31.34% below its 52-week high of $9.35, which the company reached on April 30th.

Aurora Cannabis has a 12-month low of $2.84 and a 12-month high of $9.35. The business’s 50-day moving average is $4.35 and its 200 day moving average is $5.16.